Letter of Consent is Positive Development for Valeant (VRX); Ratings May Still be Cut - Moody's

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. META
5. IBM
6. PRIM
7. SPY
8. ACN
9. NVDA
10. BLZE

Go back to Letter of Consent is Positive Development for Valeant (VRX); Ratings May Still be Cut - Moody's

Valeant Pharma (VRX) said still discussing possible sale of Bausch + Lomb - Fox News

April 8, 2016 12:30 PM EDT

Valeant Pharma (NYSE: VRX) said still discussing possible sale of Bausch + Lomb, according to Fox News.

Bankers tell @FoxBusiness... More